These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 20797487)
1. Critical appraisal of the use of cardiac resynchronization therapy beyond current guidelines. Van Bommel RJ; Delgado V; Schalij MJ; Bax JJ J Am Coll Cardiol; 2010 Aug; 56(10):754-62. PubMed ID: 20797487 [TBL] [Abstract][Full Text] [Related]
2. Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy. Bleeker GB; Schalij MJ; Holman ER; Steendijk P; van der Wall EE; Bax JJ Am J Cardiol; 2006 Jul; 98(2):230-5. PubMed ID: 16828599 [TBL] [Abstract][Full Text] [Related]
3. Cardiac resynchronization therapy in patients with a narrow QRS complex. Bleeker GB; Holman ER; Steendijk P; Boersma E; van der Wall EE; Schalij MJ; Bax JJ J Am Coll Cardiol; 2006 Dec; 48(11):2243-50. PubMed ID: 17161254 [TBL] [Abstract][Full Text] [Related]
4. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure. Abraham WT; Young JB; León AR; Adler S; Bank AJ; Hall SA; Lieberman R; Liem LB; O'Connell JB; Schroeder JS; Wheelan KR; Circulation; 2004 Nov; 110(18):2864-8. PubMed ID: 15505095 [TBL] [Abstract][Full Text] [Related]
5. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial. Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C; J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193 [TBL] [Abstract][Full Text] [Related]
6. The benefits of biventricular pacing in heart failure patients with narrow QRS, NYHA class II and right ventricular pacing. Ng K; Kedia N; Martin D; Tchou P; Natale A; Wilkoff B; Starling R; Grimm RA Pacing Clin Electrophysiol; 2007 Feb; 30(2):193-8. PubMed ID: 17338715 [TBL] [Abstract][Full Text] [Related]
7. Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure. Herweg B; Ilercil A; Cutro R; Dewhurst R; Krishnan S; Weston M; Barold SS Am J Cardiol; 2007 Jul; 100(1):90-3. PubMed ID: 17599447 [TBL] [Abstract][Full Text] [Related]
8. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure. Bonanno C; Ometto R; Pasinato S; Finocchi G; La Vecchia L; Fontanelli A Ital Heart J; 2004 May; 5(5):364-70. PubMed ID: 15185900 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of cardiac resynchronization therapy in patients with class II versus class III and IV heart failure (from the InSync/InSync ICD Italian Registry). Landolina M; Lunati M; Gasparini M; Santini M; Padeletti L; Achilli A; Bianchi S; Laurenzi F; Curnis A; Vincenti A; Valsecchi S; Denaro A; Am J Cardiol; 2007 Sep; 100(6):1007-12. PubMed ID: 17826388 [TBL] [Abstract][Full Text] [Related]
10. Three years of cardiac resynchronization therapy: could superior benefits be obtained in patients with heart failure and narrow QRS? Gasparini M; Regoli F; Galimberti P; Ceriotti C; Bonadies M; Mangiavacchi M; Andreuzzi B; Bragato R; Pini D; Klersy C; Gronda E Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S34-9. PubMed ID: 17302713 [TBL] [Abstract][Full Text] [Related]
11. Effect of cardiac resynchronization therapy in patients with moderate left ventricular systolic dysfunction and wide QRS complex: a prospective study. Fung JW; Zhang Q; Yip GW; Chan JY; Chan HC; Yu CM J Cardiovasc Electrophysiol; 2006 Dec; 17(12):1288-92. PubMed ID: 16987381 [TBL] [Abstract][Full Text] [Related]
12. Does cardiac resynchronisation therapy improve survival and quality of life in patients with end-stage heart failure? Turley AJ; Raja SG; Salhiyyah K; Nagarajan K Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1141-6. PubMed ID: 18541605 [TBL] [Abstract][Full Text] [Related]
13. Feasibility, safety, and mid-term efficacy of cardiac resynchronization therapy in patients with severe heart failure and ventricular conduction delay: Chulalongkorn experience. Sunsaneewitayakul B; Sitthisook S; Sangwatanaroj S; Prechawat S; Songmuang SB J Med Assoc Thai; 2007 Jul; 90(7):1458-66. PubMed ID: 17710992 [TBL] [Abstract][Full Text] [Related]